3 / 2017 / vol. 6
Kosmetologia Estetyczna
220
N
artykuł naukowy
DERMATOLOGIA
|
|
PODSUMOWANIE
Zapobieganie rogowaceniu naskórka jest ważne, ponieważ
stan ten może poprzedzać raka kolczystokomórkowego skóry
SCC lub być jego wczesną formą. Szerzenie wiedzy na temat
profilaktyki jest warunkiem koniecznym do ograniczania roz-
woju ognisk chorobowych.
Wiedza kosmetologów w tej dziedzinie może wpłynąć na
szybką diagnozę i sprawne leczenie dermatologiczne. Kosme-
tolodzy mogą także w znacznym stopniu przyczynić się do
zwiększania świadomości swoich klientów na temat istoty ro-
gowacenia słonecznego oraz bezpiecznego opalania.
|
|
LITERATURA
1.
A. Tirado-Sanchez, R.M. Ponce-Olivera, D. Sierra-Tellez:
Recognition of actinic kera-
tosis. A retrospective biopsy study of the clinical diagnostic accuracy by primary care
physicians compared with dermatologists. Experience in Mexico
, Our Dermatol Online,
2011, 196-198.
2.
T. Rosen, M.G. Lebwhl:
Prevalence and awareness of actinic keratosis: barriers and op-
portunities
, J Am AcadDermatol, 63, 2013, 2-9.
3.
W.D. Hoover, J.L. Jorizzo, A.R. Clark, S.R. Feldman, J. Holbrook, K.E. Huang:
Efficacy
of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of
actinic keratosis
, Cutis, 94, 2014, 255-259.
4.
A.T. Sinjab, P. Brzeziński:
Krioterapia jako alternatywne leczenie rogowiaka kolczystoko-
mórkowego. Doświadczenia własne
, Dermatol Prakt, 22, 31-36.
5.
H.K.K. Yadalla, S. Juwariya:
XerodermaPigmentosum: A Bane in developing country –
Brief report
, Our Dermatol Online, 5, 2012, 395-397.
6.
V.K. Mahajan, P.S. Chauhan, K.S. Mehta, V. Sharma:
Favre-Racouchot Syndrome
, Our
Dermatol Online, 4, 2013, 328-329.
7.
A. Włodarkiewicz, J. Narbutt, Z. Adamski, G. Chodorowska, A. Kaszuba, A. Reich,
J. Szepietowski:
Rogowacenie słoneczne – aktualny stan wiedzy. Stanowisko ekspertów
Polskiego Towarzystwa Dermatologicznego
, Przegl Dermatol, 101,2014, 156-167.
8.
P. Quatresooz, P. Pierard-Franchimont, P. Paquet, P. Hubert, P. Delvenne, G.E. Pie-
rard:
Crossroads between actinic keratosis and squamous cell carcinoma, and novel phar-
macological issues
, Eur J Dermatol, 18, 2008, 6-10.
9.
J. Malvehy:
A new vision of actinic keratosis beyond visible clinical lesions
, J Eur Acad-
Dermatol Venereol, 29, 2015, 3-8.
10.
L. Mortier, P. Marchetti, E. Delaporte, L.E. de Martin, P. Thomas, F. Piette, et al.:
Progres-
sion of actinic keratosis to squamous cel carcinoma of the skin correlates with deletion of the
9p21regionencodingthep16(INK4a)tumorsuppressor
, Cancer Lett, 176, 2002, 2005-2014.
11.
P. Kanellou, A. Zaravinos, M. Zioga, A. Stratigos, S. Baritaki, G.Soufla, et al.:
Genomic
instability, mutations and expression analysis of the tumour suppressor genes p14(ARF),
p15(INK4b), p16(INK4a) and p53 in actinic keratosis
, Cancer Lett, 264, 2008, 145-161.
12.
L. Timares, S.K. Katiyar, C.A. Elmets:
DNA damage, apoptosis and Langerhans cells –
activators of UV-induced immune tolerance
, Photochem Photobiol, 84, 2008, 422-436.
13.
S. Jackson, C. Harwood, M. Thomas, L. Banks, A. Storey:
RoleofBak inUV-inducedapop-
tosis in skin cancer and abrogation by HPV E6 proteins
, Genes Dev, 14,2000, 3065-3073.
14.
V.D. Criscione, M.A. Weinstock, M.F. Naylor, C. Luque, M.J. Eide, D.F. Bingham:
Acti-
nic keratoses: natural history and risk of malignant transformation in the Veterans Affairs
topical tretinoin chemoprevention trial
, Cancer, 115, 2009, 2523-2530.
15.
P.J. Quaedvlieg, E. Tirsi, M.R. Thissen, G.A. Krekels:
Actinic keratosis: how to differen-
tiate the good from the bad ones?
, Eur J Dermatol, 16, 2006, 335-339.
16.
B.A. Cook, A.A. Gravely, D.B. Nelson, E.M. Warshaw:
Is tenderness a reliable predictor
for differentiating squamous cel carcinomas from actinic keratoses?
, J Am Acad Dermatol,
65, 2011, 211-212.
17.
J.E. Sligh Jr:
New therapeutic options for actinic keratosis and basal cell carcinoma
, Semin
Cutan Med Surg, 33, 2014, 76-80.
18.
Y. Shibayama, S. Imafuku:
Comparison of facial predilection sites for cutaneous squamous
cell carcinoma and actinic keratosis in Japanese patients
, J Dermatol, 41, 2014, 1102-1105.
19.
H.C. Wulf:
When and why treat actinic keratoses?
, UgeskrLaeger, 176, 2014.
20.
E. Perera, S. McGuigan, R. Sinclair:
Cost for the treatment of actinic keratosis on the rise
in Australia. Version 2
, F1000Res, 3, 2014, 184.
21.
H. Bojarowicz, N. Bartnikowska:
Kosmetyki ochrony przeciwsłonecznej. Cz. II. Wybór
optymalnego preparatu
, Probl Hig Epidemiol, 95(3), 2014, 602-608.
22.
B. Stanisz:
Ochrona skóry przed negatywnymi skutkami promieniowania UV
, Farm Pol,
65(5), 2009, 363-368.
23.
A. Gwardys, C. Chwała:
Współczesne metody badania kosmetyków do opalania
, Świat
Przem Kosmet, 1(14), 2013, 18-21.
24.
D.M. Beyer, A. Faurschou, et al.:
Clothingreduces the sunprotectionfactorofsunscreens
,
Br J Dermatol, 162, 2010, 415-419.
25.
A.C. Halpern, L.J. Hanson:
Awereness of, knowledge of and attitudes to nonmelanoma
skin cancer (NMSC) and actinic keratosis (AK) among physicians
, Int J Dermatol, 43,
2004, 638-642.
26.
A.C. Halpern, L.J. Kopp:
Awareness, knowledge and attitudes to non-melanoma skin
cancer and actinic keratosis among the general public
, Int J Dermatol, 44, 2005, 107-110.
27.
M. Alam, L.H. Goldberg, S. Silapunt, E.S. Gardner, S.S. Strom, A.W. Rademaker, et al.:
Delayed treatment and continued growth of nonmelanoma skin cancer
, J Am AcadDer-
matol, 64, 2011, 839-848.
28.
L. Naldi, L. Chatenoud, R. Piccitto, P. Colombo, E.B. Placchesi, C. La Vecchia:
Prevalen-
ce of actinic keratosis and associated factors in a representative sample of the Italian adult
population;resultsfromtheprevalenceofactinickeratosis Italianstudy
,2003-2004
, Arch
Dermatol, 142, 2006, 722-726.
29.
R.M. MacKie:
Awareness, knowledge and attitudes to basal cell carcinoma and actinic
keratosis among the general public within Europe
, JEADV, 18, 2004, 552-555.
30.
C. Renzi, S. Mastroeni, T.J. Mannooranparampil, F. Passarelli, A. Caggiati, C. Proten-
za, et al.:
Delay in diagnosis and treatment of aquamous cell carcinoma of the skin
, Acta
Derm Venereol, 90, 2010, 595-601.
31.
R.F. Edlich, K.L. Winters, M.J. Cox, D.G. Becker, J.H. Horowitz, L.S. Nichter, et al.:
Nationalhealthstrategiestoreducesunexposure inAustraliaandtheUnitedStates
, J Long
Term Eff Med Implants, 14, 2004, 215-224.
32.
J.S. Lin, M. Eder, S. Weinmann:
Behavioral counseling to prevent skin cancer: a systema-
ticreviewfortheUSPreventiveServicesTaskForce
, Ann InternMed, 154, 2011, 190-201.
33.
P.F. Coogan, A. Geller, M. Adams, L.S. Benjes, H.K. Koh:
Sun protection practices in pre-
adolescents and adolescents: a school-based survey of almost 25,000 Connecticut school-
-children
, J Am Acad Dermatol, 44, 2001, 512-519.
34.
M. Montague, R. Borland, C. Sinclair:
Slip! Stop! Slap! And SunSmart, 1980-2000; skin
cancer control and 20 years of population-based campaigning
, Health Educ Behav, 28,
2001, 290-305.
35.
A. Fourtanier, D. Moyal, S. Seite:
Sunscreens containing the broad-spectrum UVA ab-
sorbet, Mexoryl SX, prevent the cutaneous detrimental effects of UV exposure: a review
of clinical study results
, Photodermatol Photoimmunol Photomed, 24, 2008, 164-174.
36.
S. Seite, D. Moyal, P.P. Verdier, C. Hourseau, A. Fourtanier:
Accumulated p53 protein
and UVA protection level of sunscreens
, Photodermatol Photoimmunol Photomed, 16,
2000, 3-9.
37.
D. Moyal, A. Fourtanier:
Broad-spectrum sunscreens provide better protection from
suppression of the elicitation phase delayed-type hypersensitivity response in humans
,
J Invest Dermatol, 117, 2000, 1186-1192.
38.
C. Ulrich, J.S. Jurgensen, A. Degen, M. Hackethal, M. Ulrich, M.J. Patel, et al.:
Pre-
vention of non-melanoma skin cancer in organ transplant patients by regular use of a sun-
screen: a 24 months, prospective, case-control sutyd
, Br J Dermatol, 161, 2009, 78-84.
